[PDF][PDF] IRAK-M expression in tumor cells supports colorectal cancer progression through reduction of antimicrobial defense and stabilization of STAT3

R Kesselring, J Glaesner, A Hiergeist, E Naschberger… - Cancer cell, 2016 - cell.com
Colorectal cancer (CRC) is associated with loss of epithelial barrier integrity, which
facilitates the interaction of the immunological microenvironment with the luminal …

Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes

AM Kamal, EF Wasfey, WR Elghamry, OM Sabry… - Clinical …, 2021 - Elsevier
Objective Accumulating evidences suggest that immune checkpoints (ICs) inhibit immune
response against cancerous cells and promote tumor cell survival. Up-regulation of ICs in …

Defining the immune checkpoint landscape in human colorectal cancer highlights the relevance of the TIGIT/CD155 axis for optimizing immunotherapy

K Ducoin, L Bilonda-Mutala, C Deleine, R Oger… - Cancers, 2022 - mdpi.com
Simple Summary One promising avenue for the treatment of colorectal cancer is the
reinvigoration of pre-existing anti-tumor T-cell responses by overcoming inhibitions that …

Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer

A Kasajima, C Sers, H Sasano, K Jöhrens… - Human pathology, 2010 - Elsevier
Antitumor inflammatory response is known to inhibit tumor growth in colorectal carcinoma.
The density and functionality of tumor-infiltrating lymphocytes (TIL) is regulated by the …

Tumor microenvironment dictates regulatory T cell phenotype: upregulated immune checkpoints reinforce suppressive function

HR Kim, HJ Park, J Son, JG Lee, KY Chung… - … for immunotherapy of …, 2019 - Springer
Abstract Background Regulatory T (T reg) cells have an immunosuppressive function in
cancer, but the underlying mechanism of immunosuppression in the tumor …

RORγt-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells

A Rizzo, M Di Giovangiulio, C Stolfi, E Franzè… - Cancer Immunology …, 2018 - AACR
Chronic inflammation drives colitis-associated colorectal cancer (CAC) in inflammatory
bowel disease (IBD). FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related …

Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells

Y Guo, F Xie, X Liu, S Ke, J Chen, Y Zhao… - Journal of Molecular …, 2023 - academic.oup.com
Enrichment of regulatory T cells (Tregs) in the tumour microenvironment (TME) has been
recognized as one of the major factors in the initiation and development of resistance to …

[PDF][PDF] The walrus and the carpenter: complex regulation of tumor immunity in colorectal cancer

G Dewson, J Silke - Cell, 2018 - cell.com
Immune infiltration has been correlated with survival of patients with colorectal cancer. In this
issue, Ziegler et al. reveal complex and unexpected connections between loss of STAT3 …

LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer

G Qiao, LB Kone, EH Phillips, SSY Lee, GE Brown… - Oncogene, 2022 - nature.com
Increased tumor infiltrating lymphocytes (TIL) are associated with improved patient
responses to immunotherapy. As a result, there is interest in enhancing lymphocyte …

CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer

SJ Lee, SY Jun, IH Lee, BW Kang, SY Park… - Journal of cancer …, 2018 - Springer
Purpose This study attempted to reveal the prognostic impact of microsatellite instability-high
(MSI-H) colon cancer with tumor-infiltrating immune cells (TIICs) and immune checkpoint …